Synthesis and biological activities of indolocarbazoles bearing amino acid residues
摘要:
Three indolocarbazole compounds bearing a tripeptide or a lysine group attached to one of the indole nitrogens via a propylamino chain and two rebeccamycin derivatives bearing a lysine residue on the sugar moiety were synthesised with the aim of improving the binding to DNA and the antiproliferative activities. Four tumour cell lines, from murine L1210 leukemia, human HT29 colon carcinoma, A549 non-small cell lung carcinoma and K-562 leukemia, were used to evaluate the cytotoxicity of the drugs. Their effects on the cell cycle of L1210 cells and their antimicrobial properties against two Gram-positive bacteria Bacillus cercus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans were also investigated. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
Synthesis and biological activities of indolocarbazoles bearing amino acid residues
摘要:
Three indolocarbazole compounds bearing a tripeptide or a lysine group attached to one of the indole nitrogens via a propylamino chain and two rebeccamycin derivatives bearing a lysine residue on the sugar moiety were synthesised with the aim of improving the binding to DNA and the antiproliferative activities. Four tumour cell lines, from murine L1210 leukemia, human HT29 colon carcinoma, A549 non-small cell lung carcinoma and K-562 leukemia, were used to evaluate the cytotoxicity of the drugs. Their effects on the cell cycle of L1210 cells and their antimicrobial properties against two Gram-positive bacteria Bacillus cercus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans were also investigated. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
[EN] COMPOUNDS FOR THE TREATMENT OF RESTENOSIS<br/>[FR] COMPOSES UTILES POUR LE TRAITEMENT DE LA RESTENOSE
申请人:THE WELLCOME FOUNDATION LIMITED
公开号:WO1996004906A1
公开(公告)日:1996-02-22
(EN) The present invention is concerned with compounds of formula (I) having use in the prophylaxis or treatment of restenosis. In particular, the invention relates to the use of these compounds in the manufacture of medicaments for the prophylaxis or treatment of restenosis, to medicaments obtained thereby, and to a method for treatment to prevent or alleviate restenosis using the compounds of the invention or a medicament containing said compounds.(FR) Composés de formule (I) utilisés dans la prophylaxie ou le traitement de la resténose. Cette invention concerne plus particulièrement l'utilisation de ces composés dans la fabrication de médicaments destinés à la prophylaxie ou au traitement de la resténose; les médicaments obtenus de cette manière; ainsi qu'un procédé de traitement permettant de prévenir ou d'atténuer la resténose à l'aide des composés de cette invention ou d'un médicament contenant ces derniers.
Synthesis and biological activities of indolocarbazoles bearing amino acid residues
作者:P Moreau
DOI:10.1016/s0223-5234(01)01284-3
日期:2001.12.1
Three indolocarbazole compounds bearing a tripeptide or a lysine group attached to one of the indole nitrogens via a propylamino chain and two rebeccamycin derivatives bearing a lysine residue on the sugar moiety were synthesised with the aim of improving the binding to DNA and the antiproliferative activities. Four tumour cell lines, from murine L1210 leukemia, human HT29 colon carcinoma, A549 non-small cell lung carcinoma and K-562 leukemia, were used to evaluate the cytotoxicity of the drugs. Their effects on the cell cycle of L1210 cells and their antimicrobial properties against two Gram-positive bacteria Bacillus cercus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans were also investigated. (C) 2001 Editions scientifiques et medicales Elsevier SAS.